NCT03474107 2026-01-09
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
Phase 3 Completed
Clinical Trials
10 trialsNCT01095003 2022-04-28
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT00545766 2021-12-16
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
SCRI Development Innovations, LLC
Phase 2 Completed
NCT02256436 2021-09-20
MK-3475-045
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01091168 2019-09-16
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02302807 2019-08-01
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
Hoffmann-La Roche
Phase 3 Completed
NCT01953003 2019-05-02
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02347332 2019-03-05
Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT00284180 2013-08-09
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00284154 2013-03-13
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed